IT1236834B - Complexes of 4-hydroxy-2-methyl-N-2-piridinyl-2-H,2-benzothiazine-3-carboxamide-1,1-dioxide with cyclodextrin, with anti-inflammatory action, procedure for their preparation and relevant pharmaceutical composition - Google Patents

Complexes of 4-hydroxy-2-methyl-N-2-piridinyl-2-H,2-benzothiazine-3-carboxamide-1,1-dioxide with cyclodextrin, with anti-inflammatory action, procedure for their preparation and relevant pharmaceutical composition

Info

Publication number
IT1236834B
IT1236834B IT02192989A IT2192989A IT1236834B IT 1236834 B IT1236834 B IT 1236834B IT 02192989 A IT02192989 A IT 02192989A IT 2192989 A IT2192989 A IT 2192989A IT 1236834 B IT1236834 B IT 1236834B
Authority
IT
Italy
Prior art keywords
piridinyl
benzothiazine
carboxamide
complexes
hydroxy
Prior art date
Application number
IT02192989A
Other languages
Italian (it)
Other versions
IT8921929A0 (en
IT8921929A1 (en
Inventor
Laura Puricelli
Original Assignee
Magis Farmaceutici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magis Farmaceutici filed Critical Magis Farmaceutici
Priority to IT02192989A priority Critical patent/IT1236834B/en
Publication of IT8921929A0 publication Critical patent/IT8921929A0/en
Publication of IT8921929A1 publication Critical patent/IT8921929A1/en
Application granted granted Critical
Publication of IT1236834B publication Critical patent/IT1236834B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The complexes of 4-hydroxy-2-methyl-N-2-piridinyl-2-H,2-benzothiazine-3-carboxamide-1,1-dioxide with α, β, γ, dimethyl-β, isopropyl-β cyclodextrin used in the anti-inflammatory treatment, are absorbed by mouth and by the rectum in far greater quantities compared to the active ingredient as is, administered in the same way.
IT02192989A 1989-10-05 1989-10-05 Complexes of 4-hydroxy-2-methyl-N-2-piridinyl-2-H,2-benzothiazine-3-carboxamide-1,1-dioxide with cyclodextrin, with anti-inflammatory action, procedure for their preparation and relevant pharmaceutical composition IT1236834B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT02192989A IT1236834B (en) 1989-10-05 1989-10-05 Complexes of 4-hydroxy-2-methyl-N-2-piridinyl-2-H,2-benzothiazine-3-carboxamide-1,1-dioxide with cyclodextrin, with anti-inflammatory action, procedure for their preparation and relevant pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02192989A IT1236834B (en) 1989-10-05 1989-10-05 Complexes of 4-hydroxy-2-methyl-N-2-piridinyl-2-H,2-benzothiazine-3-carboxamide-1,1-dioxide with cyclodextrin, with anti-inflammatory action, procedure for their preparation and relevant pharmaceutical composition

Publications (3)

Publication Number Publication Date
IT8921929A0 IT8921929A0 (en) 1989-10-05
IT8921929A1 IT8921929A1 (en) 1991-04-05
IT1236834B true IT1236834B (en) 1993-04-21

Family

ID=11188960

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02192989A IT1236834B (en) 1989-10-05 1989-10-05 Complexes of 4-hydroxy-2-methyl-N-2-piridinyl-2-H,2-benzothiazine-3-carboxamide-1,1-dioxide with cyclodextrin, with anti-inflammatory action, procedure for their preparation and relevant pharmaceutical composition

Country Status (1)

Country Link
IT (1) IT1236834B (en)

Also Published As

Publication number Publication date
IT8921929A0 (en) 1989-10-05
IT8921929A1 (en) 1991-04-05

Similar Documents

Publication Publication Date Title
KR920002144A (en) Inflammatory bowel disease prevention and treatment containing zinc L-carnosine salt or its complex as an active ingredient
YU48583B (en) Process for preparation of the formulation in the form of pill for oral dosage
ATE87319T1 (en) INCLUSION COMPLEXES OF 7-ISOPROPOXY-ISOFLAVONE WITH CYCLODEXTRINS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE INCLUSION COMPLEXES.
BRPI0108435B8 (en) formulation and use of low-dose entecavir
SE8504945D0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ANTHRACYCLINE GLYCOSIDES
IT1170214B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES
KR920017655A (en) Pharmaceutical compositions for promoting the treatment of wounds
RU95101385A (en) Products containing g-csf and tnf-binding protein
ES2125696T3 (en) USE OF TROPSY CHLORIDE FOR THE PRODUCTION OF A PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF VESIC DYSFUNCTIONS.
ATE340561T1 (en) USE OF ANTISEPTICS FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE PROPHYLAXIS AND TREATMENT OF INFLAMMATION INSIDE THE HUMAN BODY
KR910005858A (en) Fatty acid therapy
ATE147623T1 (en) MEDICINAL PREPARATION FOR PRODUCING A STABILIZED POWDER CONTAINING A COMBINATION OF ACETYLSALICYLIC ACID AND METOCLOPRAMIDE AS THE ACTIVE INGREDIENTS
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
IT1236834B (en) Complexes of 4-hydroxy-2-methyl-N-2-piridinyl-2-H,2-benzothiazine-3-carboxamide-1,1-dioxide with cyclodextrin, with anti-inflammatory action, procedure for their preparation and relevant pharmaceutical composition
KR930003913A (en) Methods and pharmaceutical compositions for enhancing the antitussive effect of dextromethorphan
KR920703060A (en) Pharmaceutical Formulations
KR870010871A (en) Intraoperative Treatment of Basal Cell Carcinoma by Recombinant Human Alpha Interferon
KR890015746A (en) How to treat AIDS cachexia with megestrol acetate
KR920017653A (en) Antitumor Compositions Containing Flunarizine
SE8804640L (en) MEDICINAL COMPREHENSIVE CYCLOLINOPEPTIDE A
KR900017599A (en) Pharmaceutical composition for tumor treatment
KR920700641A (en) Use for the prevention and / or treatment of neurodegeneration of chlormethazole
ATE139703T1 (en) MEDICINAL PRODUCT CONTAINING AUREOBASIDINE
KR870005642A (en) Mixture of Diflunisal and Tromethamine
IT1243368B (en) Use of bendazac and of its pharmaceutically acceptable salts

Legal Events

Date Code Title Description
0001 Granted